Seasonal Allergic Rhinitis
Conditions
Interventions
experimental group:Acupuncture treatment. According to patients' previous attack time, acupuncture intervention are given in advance 4 weeks before the onset of the disease, and acupuncture treatment
control group:Acupuncture treatment. The patient did not receive any intervention before the onset of the disease, and was given acupuncture treatment for 4 weeks during the episode of disease.
Sponsors
Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria of moderate and severe seasonal allergic rhinitis; (2) Subjects with positive reactions to seasonal inhalation allergens such as pollen and fungi in skin prick test; (3) Subjects with a history of seasonal allergic rhinitis for at least 2 yearswho have a fixed onset time each year and are currently in remission; (4) The average total nasal symptom score(TNSS)=4 during the episode in the past year; (5) Subjects aged between 18-65 years old; (6) Subjects who volunteer to participate in the clinical study, and are able to answer relevant scale questions truthfully as required, recorded the use of anti-allergy drugs, and signed informed consent. Only those who meet the above six items can be included.
Exclusion criteria
Exclusion criteria: (1) Subjects who have a history of chronic paranasal sinusitis, or who are found to have chronic paranasal sinusitis by paranasal sinus X-ray examination; (2) Subjects who have organic lesions in the nasal cavity or who have undergone nasal surgery; (3) Subjects with respiratory tract infection or acute sinusitis within the past 2 weeks; patients with inflammation on chest X-ray; (4) Subjects who have received western medicine (H1-antihistamines, glucocorticoids, leukotriene receptor antagonists, mast cell membrane stabilizers, decongestants and anticholinergics, etc.), traditional Chinese medicines, etc. via nasal cavity, oral cavity or systemic route in the past 2 weeks which may affect the results of clinical study; (5) Subjects who have received physical therapy within the range of traditional medicine such as acupuncture, moxibustion, cupping, and intranasal Chinese medicine inhalation in the past 2 weeks; (6) Subjects who have received specific immunotherapy or systemic hormone therapy within the past 1 year; (7) Subjects complicated with other respiratory diseases, such as asthma, etc.; (8) Subjects complicated with severe liver or kidney dysfunction or other serious diseases, who cannot receive treatment; (9) People with serious mental illness or violent tendencies; (10) Pregnant or lactating women, and women who are planning to become pregnant during the trial; (11) Concurrently participating in other clinical trials. Those who meet any of the above items will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total nasal symptom scores (TNSS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient acceptance;attack rate;Rhinoconjunctivitis quality of life questionnaire(RQLQ);Rescue medication score (RMS);Total nonnasal symptom score (TNNSS);Patient satisfaction; | — |
Countries
China
Contacts
Public ContactJiping Zhao
Outcome results
None listed